特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
950818

細胞および遺伝子治療ツールと試薬の世界市場

Cell and Gene Therapy Tools, and Reagents: Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 71 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
細胞および遺伝子治療ツールと試薬の世界市場
出版日: 2020年07月21日
発行: BCC Research
ページ情報: 英文 71 Pages
納期: 即納可能 即納可能とは
担当者のコメント
細胞療法及び遺伝子療法で使用されるツールと試薬に着目し、Gene Vectors、GMP Proteins、GMP Antibodies、Bioreactors、Multiplex Immunoassays、Immunoassays、Leukaphresis、Cell Separation、Cytokine Release Syndrome Monitoring、Mediaの10Type別に2024年までの市場規模を算出しております。オンライン試読など可能ですのでまずはお問合せください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のライフサイエンスツール市場は、2019年に65億米ドルとなりました。同市場は、2019年から2024年の予測期間中に8.5%のCAGRで成長する見通しで、2024年には90億米ドルに達すると予測されています。また、予測期間中に北米市場は8%、欧州市場は7.6%のCAGRで成長すると予測されています。

当レポートは、世界の細胞および遺伝子治療ツールと試薬市場について調査しており、市場機会、シェア、政府の規制、地域・エンドユーザー別の市場の内訳、開発、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 結論とハイライト

  • 治療法の進化と拡大
  • CRISPRの役割
  • 新しいベクター・新しいソリューション
  • 細胞療法の成長
  • 支払者のポリシーによる可能性の証明
  • コロナウイルスクラウン

第3章 市場と技術の背景

  • 概要:細胞および遺伝子治療の始まりと現状
  • 細胞および遺伝子治療タイプ
  • 使用される一般的な機器
  • 産業構造
  • 主要参入企業と市場シェア

第4章 市場の内訳:地域別

  • 細胞および遺伝子治療装置

第5章 市場の内訳:エンドユーザー別

第6章 政府規制

  • 遺伝子治療に関する規制の範囲
  • ウイルスおよび非ウイルスベクター
  • メディア
  • GMPタンパク質と抗体
  • 細胞療法
  • 白血球除去
  • 細胞治療、遺伝子治療、EMA

第7章 特許レビュー/新しい開発

  • 細胞および遺伝子治療の研究開発
  • 学術研究機関
  • 産業の変化
  • 最近の投資
  • 技術
  • 技術の現状

第8章 市場機会の分析

  • 細胞および遺伝子治療のケーススタディ
  • 臨床診断
  • 製薬/バイオテクノロジー

第9章 企業プロファイル

  • ABCAM
  • ADVERUM BIOTECHNOLOGIES
  • ATHERSYS INC.
  • AVROBIO
  • BIO-RAD LABORATORIES
  • BIO-TECHNE
  • CELLGENIX
  • CYTIVA LIFE SCIENCES
  • LUMINEX CORP.
  • MESOBLAST LTD.
  • MILLIPORE SIGMA
  • MILTENYI BIOTEC
  • ORGANICELL
  • QUANTERIX
  • SARTORIUS
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER
図表

List of Tables

  • Summary Table : Global Market for Life Science Tools, by Region, Through 2024
  • Table 1 : Global Market for Academic Life Science Tools, by Region, Through 2024
  • Table 2 : Global Market for Clinical Life Science Tools, by Region, Through 2024
  • Table 3 : Global Market for Biotech Life Science Tools, by Region, Through 2024
  • Table 4 : Global Market for GMP Proteins, by Region, Through 2024
  • Table 5 : Global Market for Academic GMP Proteins, by Region, Through 2024
  • Table 6 : Global Market for Clinical GMP Proteins, by Region, Through 2024
  • Table 7 : Global Market for Biotech GMP Proteins, by Region, Through 2024
  • Table 8 : Global Market for Media, by Region, Through 2024
  • Table 9 : Global Market for Academic Media, by Region, Through 2024
  • Table 10 : Global Market for Clinical Media, by Region, Through 2024
  • Table 11 : Global Market for Biotech Media, by Region, Through 2024
  • Table 12 : Global Market for Cell Separation, by Region, Through 2024
  • Table 13 : Global Market for Academic Cell Separation, by Region, Through 2024
  • Table 14 : Global Market for Biotech Cell Separation, by Region, Through 2024
  • Table 15 : Global Market for Clinical Cell Separation, by Region, Through 2024
  • Table 16 : Global Market for Gene Vectors, by Region, Through 2024
  • Table 17 : Global Market for Academic Gene Vectors, by Region, Through 2024
  • Table 18 : Global Market for Clinical Gene Vectors, by Region, Through 2024
  • Table 19 : Global Market for Biotech Gene Vectors, by Region, Through 2024
  • Table 20 : Global Market for Cytokine Release Syndrome Testing, by Region, Through 2024
  • Table 21 : Global Market for Academic Cytokine Release Syndrome Testing, by Region, Through 2024
  • Table 22 : Global Market for Clinical Cytokine Release Syndrome Testing, by Region, Through 2024
  • Table 23 : Global Market for Biotech Cytokine Release Syndrome Testing, by Region, Through 2024
  • Table 24 : Global Market for GMP Antibodies, by Region, Through 2024
  • Table 25 : Global Market for Academic GMP Antibodies, by Region, Through 2024
  • Table 26 : Global Market for Clinical GMP Antibodies, by Region, Through 2024
  • Table 27 : Global Market for Biotech GMP Antibodies, by Region, Through 2024
  • Table 28 : Global Market for Leukapheresis, by Region, Through 2024
  • Table 29 : Global Market for Academic Leukapheresis, by Region, Through 2024
  • Table 30 : Global Market for Biotech Leukapheresis, by Region, Through 2024
  • Table 31 : Global Market for Clinical Leukapheresis, by Region, Through 2024
  • Table 32 : Global Market for Bioreactors, by Region, Through 2024
  • Table 33 : Global Market for Academic Bioreactors, by Region, Through 2024
  • Table 34 : Global Market for Biotech Bioreactors, by Region, Through 2024
  • Table 35 : Global Market for Clinical Bioreactors, by Region, Through 2024
  • Table 36 : Global Market for Research Use-Only Immunoassays, by Region, Through 2024
  • Table 37 : Global Market for Academic Research Use-Only Immunoassays, by Region, Through 2024
  • Table 38 : Global Market for Clinical Research Use-Only Immunoassays, by Region, Through 2024
  • Table 39 : Global Market for Biotech Research Use-Only Immunoassays, by Region, Through 2024
  • Table 40 : Global Market for Research Use-Only Multiplex Immunoassays, by Region, Through 2024
  • Table 41 : Global Market for Academic Research-Use Only Multiplex Immunoassays, by Region, Through 2024
  • Table 42 : Global Market for Clinical Research Use-Only Multiplex Immunoassays, by Region, Through 2024
  • Table 43 : Global Market for Biotech Research Use-Only Multiplex Immunoassays, by Region, Through 2024
  • Table 44 : Global Market for Cancer Life Science Tools, by Region, Through 2024
  • Table 45 : Global Market for Blood Disorder Life Science Tools, by Region, Through 2024
  • Table 46 : Global Market for Life Science Tools for Other Diseases, by Region, Through 2024
  • Table 47 : Global Market for Cancer GMP Proteins, by Region, Through 2024
  • Table 48 : Global Market for Blood Disorder GMP Proteins, by Region, Through 2024
  • Table 49 : Global Market for GMP Proteins for Other Diseases, by Region, Through 2024
  • Table 50 : Global Market for Cancer Media, by Region, Through 2024
  • Table 51 : Global Market for Blood Disorder Media, by Region, Through 2024
  • Table 52 : Global Market for Media for Other Diseases, by Region, Through 2024
  • Table 53 : Global Market for Cancer Cell Separation, by Region, Through 2024
  • Table 54 : Global Market for Blood Disorder Cell Separation, by Region, Through 2024
  • Table 55 : Global Market for Cell Separation for Other Diseases, by Region, Through 2024
  • Table 56 : Global Market for Cancer Gene Vectors, by Region, Through 2024
  • Table 57 : Global Market for Blood Disorder Gene Vectors, by Region, Through 2024
  • Table 58 : Global Market for Gene Vectors for Other Diseases, by Region, Through 2024
  • Table 59 : Global Market for Cancer Cytokine Release Syndrome Testing, by Region, Through 2024
  • Table 60 : Global Market for Blood Disorder Cytokine Release Testing, by Region, Through 2024
  • Table 61 : Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2024
  • Table 62 : Global Market for Cancer GMP Antibodies, by Region, Through 2024
  • Table 63 : Global Market for Blood Disorder GMP Antibodies, by Region, Through 2024
  • Table 64 : Global Market for GMP Antibodies for Other Diseases, by Region, Through 2024
  • Table 65 : Global Market for Cancer Leukapheresis, by Region, Through 2024
  • Table 66 : Global Market for Blood Disorder Leukapheresis, by Region, Through 2024
  • Table 67 : Global Market for Leukapheresis for Other Diseases, by Region, Through 2024
  • Table 68 : Global Market for Cancer Bioreactors, by Region, Through 2024
  • Table 69 : Global Market for Blood Disorder Bioreactors, by Region, Through 2024
  • Table 70 : Global Market for Bioreactors for Other Diseases, by Region, Through 2024
  • Table 71 : Global Market for Cancer Immunoassays, by Region, Through 2024
  • Table 72 : Global Market for Blood Disorder Immunoassays, by Region, Through 2024
  • Table 73 : Global Market for Immunoassays for Other Diseases, by Region, Through 2024
  • Table 74 : Global Market for Cancer Multiplex Immunoassays, by Region, Through 2024
  • Table 75 : Global Market for Blood Disorder Multiplex Immunoassays, by Region, Through 2024
  • Table 76 : Global Market for Multiplex Immunoassays for Other Diseases, by Region, Through 2024

List of Figures

  • Summary Figure : Global Market for Life Science Tools, by Region, 2017-2024
目次
Product Code: BIO208A

Highlights:

The global market for life science tools should grow from $6.5 billion in 2019 to reach $9.0 billion by 2024 at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2019-2024.

The North American market for life science tools should grow from $1.9 billion in 2019 to reach $2.8 billion by 2024 at a CAGR of 8.0% during the forecast period of 2019-2024.

The European market for life science tools should grow from $2.2 billion in 2019 to reach $3.2 billion by 2024 at a CAGR of 7.6% during the forecast period of 2019-2024.

Report Scope:

The scope of this study encompasses an investigation of the markets cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. BCC Research analyzes the industry on a worldwide basis, from both application and demand perspectives, in the major regions of the world.

Report Includes:

  • 77 data tables
  • An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
  • Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information about in vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion on prevalence of infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
  • Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays and rapid diagnostic technologies
  • Evaluation of market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Evolution and Expansion of Therapies
  • Role for CRISPR?
  • New Vectors, New Solutions
  • Cell Therapy is Growing
  • Payor Policy Proves Potential
  • Coronavirus Crown?

Chapter 3 Market and Technology Background

  • Overview: Beginnings and Current State of Cell and Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • Types of Cell and Gene Therapy
  • Gene Therapy
  • Cell Therapy
  • Common Equipment Used
  • Industry Structure
  • Major Companies and Market Share

Chapter 4 Market Breakdown by Region

  • Cell and Gene Therapy Equipment

Chapter 5 Market Breakdown by End User

Chapter 6 Government Regulations

  • Scope of Regulations on Gene Therapy
  • Viral and Non-Viral Vectors
  • Media
  • GMP Proteins and Antibodies
  • Cell Therapy
  • Leukapheresis
  • Cell Therapy, Gene Therapy and the EMA

Chapter 7 Patent Review/New Developments

  • Cell and Gene Therapy R&D
  • Academia
  • Industrial Changes
  • Recent Investments
  • Technology
  • Current State of Technology

Chapter 8 Analysis of Market Opportunities

  • Case Studies of Cell and Gene Therapy
  • Clinical Diagnostics
  • Pharmaceutical/Biotechnology

Chapter 9 Company Profiles

  • ABCAM
  • ADVERUM BIOTECHNOLOGIES
  • ATHERSYS INC.
  • AVROBIO
  • BIO-RAD LABORATORIES
  • BIO-TECHNE
  • CELLGENIX
  • CYTIVA LIFE SCIENCES
  • LUMINEX CORP.
  • MESOBLAST LTD.
  • MILLIPORE SIGMA
  • MILTENYI BIOTEC
  • ORGANICELL
  • QUANTERIX
  • SARTORIUS
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.